Stephen Shiu-Wah Chung

Sloan-Kettering Inst Can Research

$2,312,569

Attributed

$2,312,569

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $518.9K · FY2017–25

$1M$750K$500K$250K$0

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$2,312,569 · 2

By mechanism

R37$1,469,725 · 1

K08$842,844 · 1

Top collaborators

No co-investigators on record.

Most similar at Sloan-Kettering Inst Can Research

Same institution · by research overlap

Michael Kharas$18,485,709
Megan S. Lim$4,964,836
Andrew Michael Intlekofer$5,190,407
Kayvan R Keshari$12,246,491
Mengmeng Du$2,352,665

Others in their field

Other Emerging Leaders on “Malignant Neoplasms”

Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
Martha Hering · Westat, Inc.$57,098,843

Research focus

Malignant NeoplasmsEvaluationTherapy ResistantTranslatingHematopoietic Stem CellsCellsResponseSelf-RenewalImpairmentNovel TherapeuticsRegulationMouse ModelCell SurfaceProteinsCancer Stem CellAcute Myelocytic LeukemiaProgramsRecurrent DiseaseMolecularMonoclonal AntibodiesIn VivoClinicLeukemic Stem CellMediating